Multi-omics analysis reveals the crosstalk of epigenetic regulatory networks in cutaneous squamous cell carcinoma progression
Open Access
- 13 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 23 (1) , 1281
Abstract
Cutaneous squamous cell carcinoma (cSCC) is the second most common form of non-melanoma skin cancer (NMSC), with a steadily increasing global incidence, especially in populations with prolonged ultraviolet (UV) exposure. Advanced or metastatic cSCC carries a poor prognosis, while the application of targeted therapies and immunotherapies remains in the exploratory stage, due to limited understanding of the underlying mechanisms of cSCC occurrence and progression. Epigenetic dysregulation plays important roles in the progression of cSCC. However, how multi-dimensional regulatory networks reshape the epigenetic landscape and contribute to dysregulated gene expression in cSCC remains unclear. In this study, we performed parallel RNA m6A sequencing, 850K DNA methylation arrays, whole transcriptome sequencing, and ATAC-seq chromatin accessibility profiling on samples from normal skin, actinic keratosis (AK), and cSCC. We analyzed the regulatory networks and pathways of epigenetic modifications on gene expression. We further explored the crosstalk of epigenetic regulatory networks by correlation analysis. By integrating single-cell RNA-seq data, we identified epigenetically upregulated candidate genes and confirmed their expression and functions with experimental methods. Our integrated multi-omics analysis provides a comprehensive and dynamic epigenetic map of cSCC progression. Further analysis revealed that DNA methylation and m6A modification jointly regulate gene expression through independent and synergistic ways. The identified epigenetically upregulated candidate genes IDO1, IFI6, and OAS2 were validated to be overexpressed in cSCC tissues and cell lines, and functional assays confirmed their potential key roles in regulating the processes of cell proliferation, migration and invasion in cSCC. By integrating multi-omics data, this study systematically highlights the multi-layered epigenetic alterations and regulatory mechanisms involved in cSCC development. This multi-stage, multi-omics, and multi-resolution integrated analysis provides a theoretical basis and new insights for future personalized treatment strategies for cSCC.Keywords
This publication has 59 references indexed in Scilit:
- A prospective cohort study evaluating m6A RNA methylation in cutaneous squamous cell carcinomaJournal of the American Academy of Dermatology, 2023
- Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapyCancer Treatment Reviews, 2022
- UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymesEBioMedicine, 2020
- METTL3 mediated m6A modification plays an oncogenic role in cutaneous squamous cell carcinoma by regulating ΔNp63Biochemical and Biophysical Research Communications, 2019
- Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort StudyJournal of Investigative Dermatology, 2017
- Human epidermal stem cells: Role in adverse skin reactions and carcinogenesis from radiationMutation Research - Reviews in Mutation Research, 2016
- Comparison of DNA Methylation and Expression Pattern of S100 and Other Epidermal Differentiation Complex Genes in Differentiating KeratinocytesJournal of Cellular Biochemistry, 2015
- N6-methyladenosine Modulates Messenger RNA Translation EfficiencyCell, 2015
- Actinic keratosis: Facts and controversiesClinics in Dermatology, 2010
- Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006Archives of Dermatology, 2010